Price $3.39 |
Market Cap
91.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.22
|
P/S
94.88
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-26.6K
|
FCF
-1.2
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-105.70%
|
ROI
-114.60%
|
|
ROA
-82.80%
|
EPS Growth
14.10%
|
Current Ratio
5.6
|
Debt/Equity
1.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.03 | - | - | 6.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
